| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.07 | 0.6 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |